Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andy Ryan

Showing results (61-70 of 76) with videos related to

Pageof 8
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 28, 2017
Evidence of Stage Shift in Women Diagnosed With Ovarian Cancer During Phase II of the United Kingdom Familial Ovarian Cancer Screening StudyAdam N Rosenthal, Lindsay S M Fraser, Susan Philpott, et al.
Journal of Medical Genetics|November 30, 2021
Comprehensive epithelial tubo-ovarian cancer risk prediction model incorporating genetic and epidemiological risk factorsAndrew Lee, Xin Yang, Jonathan Tyrer, et al.
Trials|March 3, 2011
Impact on mortality and cancer incidence rates of using random invitation from population registers for recruitment to trialsMatthew Burnell, Aleksandra Gentry-Maharaj, Andy Ryan, et al.
BMJ (Clinical Research Ed.)|November 15, 2008
Recruitment to multicentre trials--lessons from UKCTOCS: descriptive studyUsha Menon, Aleksandra Gentry-Maharaj, Andy Ryan, et al.
Nature Communications|February 2, 2022
The WID-BC-index identifies women with primary poor prognostic breast cancer based on DNA methylation in cervical samplesJames E Barrett, Chiara Herzog, Allison Jones, et al.
British Journal of Cancer|July 26, 2017
The cost-effectiveness of screening for ovarian cancer: results from the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)Usha Menon, Alistair J McGuire, Maria Raikou, et al.
The Lancet. Oncology|March 14, 2009
Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)Usha Menon, Aleksandra Gentry-Maharaj, Rachel Hallett, et al.
Lancet (London, England)|May 15, 2021
Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trialUsha Menon, Aleksandra Gentry-Maharaj, Matthew Burnell, et al.
International Journal of Epidemiology|November 22, 2020
Metabolic profiles of socio-economic position: a multi-cohort analysisOliver Robinson, Alice R Carter, Mika Ala-Korpela, et al.
The Lancet. Oncology|December 15, 2010
Sensitivity of transvaginal ultrasound screening for endometrial cancer in postmenopausal women: a case-control study within the UKCTOCS cohortIan Jacobs, Aleksandra Gentry-Maharaj, Matthew Burnell, et al.
Pageof 8

Showing results (61-70 of 76) with videos related to

Sort By:
Pageof 8
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 28, 2017
Evidence of Stage Shift in Women Diagnosed With Ovarian Cancer During Phase II of the United Kingdom Familial Ovarian Cancer Screening StudyAdam N Rosenthal, Lindsay S M Fraser, Susan Philpott, et al.
Journal of Medical Genetics|November 30, 2021
Comprehensive epithelial tubo-ovarian cancer risk prediction model incorporating genetic and epidemiological risk factorsAndrew Lee, Xin Yang, Jonathan Tyrer, et al.
Trials|March 3, 2011
Impact on mortality and cancer incidence rates of using random invitation from population registers for recruitment to trialsMatthew Burnell, Aleksandra Gentry-Maharaj, Andy Ryan, et al.
BMJ (Clinical Research Ed.)|November 15, 2008
Recruitment to multicentre trials--lessons from UKCTOCS: descriptive studyUsha Menon, Aleksandra Gentry-Maharaj, Andy Ryan, et al.
Nature Communications|February 2, 2022
The WID-BC-index identifies women with primary poor prognostic breast cancer based on DNA methylation in cervical samplesJames E Barrett, Chiara Herzog, Allison Jones, et al.
British Journal of Cancer|July 26, 2017
The cost-effectiveness of screening for ovarian cancer: results from the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)Usha Menon, Alistair J McGuire, Maria Raikou, et al.
The Lancet. Oncology|March 14, 2009
Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)Usha Menon, Aleksandra Gentry-Maharaj, Rachel Hallett, et al.
Lancet (London, England)|May 15, 2021
Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trialUsha Menon, Aleksandra Gentry-Maharaj, Matthew Burnell, et al.
International Journal of Epidemiology|November 22, 2020
Metabolic profiles of socio-economic position: a multi-cohort analysisOliver Robinson, Alice R Carter, Mika Ala-Korpela, et al.
The Lancet. Oncology|December 15, 2010
Sensitivity of transvaginal ultrasound screening for endometrial cancer in postmenopausal women: a case-control study within the UKCTOCS cohortIan Jacobs, Aleksandra Gentry-Maharaj, Matthew Burnell, et al.
Pageof 8